IP Verse

Methods For Treating Atopic Dermatitis By Administering An Il-4R Antagonist

Patent No. EP2892927 (titled "Methods For Treating Atopic Dermatitis By Administering An Il-4R Antagonist") was filed by Regeneron Pharmaceuticals on Sep 4, 2013. The application was issued on May 9, 2018.

Patent Summary

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
BREUER	Feb 6, 2019	BREUER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Jan 8, 2020
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Jan 8, 2020
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Jan 2, 2020
Termination of the opposition proceedings with revocation of patent
Oct 1, 2019
Advice of delivery
Sep 30, 2019
Advice of delivery
Sep 30, 2019
Advice of delivery
Sep 26, 2019
Advice of delivery
Sep 20, 2019
Acknowledgement of a document
Sep 20, 2019
Acknowledgement of a document
Sep 20, 2019
Decision revoking the European patent
Sep 20, 2019
Decision revoking the European patent
Sep 18, 2019
Brief communication - Opposition proceedings
Sep 18, 2019
Brief communication in opposition procedure - time limit
Sep 16, 2019
Brief communication - Opposition proceedings
Sep 12, 2019
(Electronic) Receipt
Sep 12, 2019
Request for revocation of patent
Sep 10, 2019
Brief communication - Opposition proceedings
Sep 10, 2019
Communication of amended entries
Sep 5, 2019
(Electronic) Receipt
Sep 5, 2019
Letter accompanying subsequently filed items
Sep 5, 2019
Request for revocation of patent
Aug 30, 2019
Request for change of opponent's representative
Aug 28, 2019
Request for change of opponent's representative
May 7, 2019
Brief communication - Opposition proceedings
May 7, 2019
Grant of extension of time limit (opposition procedure)
Apr 25, 2019
(Electronic) Receipt
Apr 25, 2019
Letter accompanying subsequently filed items
Apr 25, 2019
Request for extension of time limit
Mar 14, 2019
Communication confirming withdrawal from representation
Mar 14, 2019
Communication of amended entries concerning the representative
Mar 8, 2019
(Electronic) Receipt
Mar 8, 2019
Letter accompanying subsequently filed items
Mar 8, 2019
Submission concerning change of proprietor's representative
Feb 25, 2019
Communication of a notice of opposition and request to file observations
Feb 25, 2019
Notice of further oppositions to opponent(s)
Feb 22, 2019
Communication of a notice of opposition - first information to patent proprietor
Feb 6, 2019
Citation in opposition procedure
Feb 6, 2019
Citation in opposition procedure
Feb 6, 2019
Citation in opposition procedure
Feb 6, 2019
Citation in opposition procedure
Feb 6, 2019
Citation in opposition procedure
Feb 6, 2019
Citation in opposition procedure
Feb 6, 2019
Citation in opposition procedure
Feb 6, 2019
Citation in opposition procedure
Feb 6, 2019
Citation in opposition procedure
Feb 6, 2019
Citation in opposition procedure
Feb 6, 2019
Citation in opposition procedure
Feb 6, 2019
Citation in opposition procedure
Feb 6, 2019
Citation in opposition procedure
Feb 6, 2019
Non-patent literature cited during the opposition procedure
Feb 6, 2019
Non-patent literature cited during the opposition procedure
Feb 6, 2019
Non-patent literature cited during the opposition procedure
Feb 6, 2019
Non-patent literature cited during the opposition procedure
Feb 6, 2019
Non-patent literature cited during the opposition procedure
Feb 6, 2019
Non-patent literature cited during the opposition procedure
Feb 6, 2019
Non-patent literature cited during the opposition procedure
Feb 6, 2019
Non-patent literature cited during the opposition procedure
Feb 6, 2019
Non-patent literature cited during the opposition procedure
Feb 6, 2019
Non-patent literature cited during the opposition procedure
Feb 6, 2019
Notice of opposition
Feb 6, 2019
Patent document cited during the opposition procedure
Feb 6, 2019
Patent document cited during the opposition procedure
Feb 6, 2019
Patent document cited during the opposition procedure
May 22, 2018
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Apr 12, 2018
Decision to grant a European patent
Mar 29, 2018
Bibliographic data of the European patent application
Mar 29, 2018
Information about intention to grant a patent
Mar 29, 2018
Intention to grant (signatures)
Mar 29, 2018
Text intended for grant (clean copy)
Mar 29, 2018
Text intended for grant (sequence listing)
Mar 29, 2018
Text intended for grant (version for approval)
Mar 22, 2018
Processing of request for correction of text proposed for grant or third party observations (from 01-04-2012)
Mar 14, 2018
(Electronic) Receipt
Mar 14, 2018
Amended claims with annotations
Mar 14, 2018
Annex
Mar 14, 2018
Claims
Mar 14, 2018
French translation of claims
Mar 14, 2018
German translation of the claims
Mar 14, 2018
Letter accompanying subsequently filed items
Mar 14, 2018
Request for correction/amendment of the text proposed for grant sent from 01.04.2012
Nov 6, 2017
Bibliographic data of the European patent application
Nov 6, 2017
Communication about intention to grant a European patent
Nov 6, 2017
Intention to grant (signatures)
Nov 6, 2017
Text intended for grant (clean copy)
Nov 6, 2017
Text intended for grant (sequence listing)
Nov 6, 2017
Text intended for grant (version for approval)
Oct 26, 2017
Annex to a communication
Oct 26, 2017
Annex to the communication
Oct 26, 2017
Consultation by telephone/in person
Oct 26, 2017
Result of consultation by telephone/in person
Sep 4, 2017
(Electronic) Receipt
Sep 4, 2017
Amended claims with annotations
Sep 4, 2017
Amended description with annotations
Sep 4, 2017
Claims
Sep 4, 2017
Description
Sep 4, 2017
Letter accompanying subsequently filed items
Sep 4, 2017
Reply to communication from the Examining Division
Jun 12, 2017
Communication of amended entries concerning the representative
Jun 7, 2017
Submission concerning change of applicant's representative
Jun 6, 2017
Submission concerning change of applicant's representative
May 3, 2017
Annex to the communication
May 3, 2017
Communication from the Examining Division
Jan 6, 2017
(Electronic) Receipt
Jan 6, 2017
Amended claims with annotations
Jan 6, 2017
Claims
Jan 6, 2017
Letter accompanying subsequently filed items
Jan 6, 2017
Non-patent literature cited during the examination procedure
Jan 6, 2017
Non-patent literature cited during the examination procedure
Jan 6, 2017
Reply to communication from the Examining Division
Oct 27, 2016
Grant of extension of time limit (examination procedure)
Oct 24, 2016
(Electronic) Receipt
Oct 24, 2016
Letter accompanying subsequently filed items
Oct 24, 2016
Request for extension of time limit to communication from the Examining Division
Jun 28, 2016
Annex to the communication
Jun 28, 2016
Communication from the Examining Division
Jun 21, 2016
Examination started
Feb 16, 2016
Communication of the registration of a transfer or change of name and/or address
Jan 14, 2016
(Electronic) Receipt
Jan 14, 2016
Annexes in respect of a client data request
Jan 14, 2016
Annexes in respect of a client data request
Jan 14, 2016
Letter accompanying subsequently filed items
Jan 14, 2016
Submission concerning a transfer of rights (applicant)
Jan 13, 2016
(Electronic) Receipt
Jan 13, 2016
Letter accompanying subsequently filed items
Jan 13, 2016
Reply to invitation to file a copy of priority search results
Dec 3, 2015
Invitation to file a copy of search results(priority)
Oct 20, 2015
(Electronic) Receipt
Oct 20, 2015
Amended claims filed after receipt of (European) search report
Oct 20, 2015
Amendments received before examination
Oct 20, 2015
Letter accompanying subsequently filed items
Jun 17, 2015
Notification on forthcoming publication of bibliographic data
Apr 15, 2015
Communication regarding comments on written opinion/amendment of application/payment of claims fee
Apr 13, 2015
Communication to designated inventor
Apr 13, 2015
Communication to designated inventor
Apr 13, 2015
Communication to designated inventor
Apr 13, 2015
Communication to designated inventor
Apr 13, 2015
Communication to designated inventor
Apr 13, 2015
Communication to designated inventor
Apr 13, 2015
Communication to designated inventor
Apr 13, 2015
Communication to designated inventor
Apr 13, 2015
Communication to designated inventor
Mar 23, 2015
Copy of the international preliminary report on patentability
Feb 9, 2015
(Electronic) Receipt
Feb 9, 2015
Amended claims filed after receipt of (European) search report
Feb 9, 2015
Amended claims with annotations
Feb 9, 2015
Amendments received before examination
Feb 9, 2015
Request for entry into the European phase
Jan 16, 2015
Information on entry into European phase
Nov 18, 2014
Notification of the recording of a change
Nov 18, 2014
Notification of the recording of a change
Nov 18, 2014
Notification of the recording of a change
Sep 4, 2014
Annex
Apr 1, 2014
Priority document (electronically transmitted)
Apr 1, 2014
Priority document (electronically transmitted)
Apr 1, 2014
Priority document (electronically transmitted)
Apr 1, 2014
Priority document (electronically transmitted)
Apr 1, 2014
Priority document (electronically transmitted)
Apr 1, 2014
Priority document (electronically transmitted)
Apr 1, 2014
Priority document (electronically transmitted)
Apr 1, 2014
Priority document (electronically transmitted)
Apr 1, 2014
Priority document (electronically transmitted)
Mar 13, 2014
Converted Sequence Listing
Mar 13, 2014
Copy of the international search report
Mar 13, 2014
Published international application - A1
Mar 13, 2014
Sequence listing
Feb 12, 2014
Written opinion of the ISA, boxes No. I to VIII
Feb 12, 2014
Written opinion of the ISA, cover sheet
Feb 12, 2014
Written opinion of the ISA, supplemental box
Sep 16, 2013
Abstract
Sep 16, 2013
Claims
Sep 16, 2013
Description
Sep 16, 2013
Drawings
Sep 16, 2013
Sequence listing

EP2892927

REGENERON PHARMACEUTICALS

Application Number: EP13765844A
Filing Date: Sep 4, 2013
Status: Revoked; Jan 3, 2020
Publication Date: May 9, 2018
External Links: Slate, Register , Google Patents